OTC Drug Industry Could Stand To Gain With 'Pragmatist' In White House
This article was originally published in The Pink Sheet
Executive Summary
With the Trump administration ahead, CHPA's highest regulatory priorities include eliminating a requirement from the Obama era that consumers get a prescription in order to pay for OTC drugs with pre-tax savings accounts and improving the Nixon-era monograph program.